|
Powered by Cell Signaling Technology |
Site Information |
---|
NCDLEQQsIVHIVQR SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 25538008 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Regulatory protein: | |
Putative in vivo kinases: | |
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on PARK2: | |
Effects of modification on biological processes: |
References | |
---|---|
Li Z, et al. (2022) Increasing brain glucose metabolism by ligustrazine piperazine ameliorates cognitive deficits through PPARγ-dependent enhancement of mitophagy in APP/PS1 mice. Alzheimers Res Ther 14, 150
36217155 Curated Info |
|
Yang J, et al. (2022) Pitavastatin activates mitophagy to protect EPC proliferation through a calcium-dependent CAMK1-PINK1 pathway in atherosclerotic mice. Commun Biol 5, 124
35145192 Curated Info |
|
Kim M, et al. (2022) Evaluation of Parkin in the Regulation of Myocardial Mitochondria-Associated Membranes and Cardiomyopathy During Endotoxemia. Front Cell Dev Biol 10, 796061
35265609 Curated Info |
|
Bhupana JN, et al. (2020) Gas7 knockout affects PINK1 expression and mitochondrial dynamics in mouse cortical neurons. FASEB Bioadv
32161906 Curated Info |
|
Lee SB, et al. (2019) The AMPK-Parkin axis negatively regulates necroptosis and tumorigenesis by inhibiting the necrosome. Nat Cell Biol 21, 940-951
31358971 Curated Info |